Mobile app-maker Vital Art & Science is looking for a pharmaceutical-industry partner after raising $550,000 in support of its MyVisionTrack iPhone vision test.
Texas mobile health startup Vital Art & Science is looking for a pharmaceutical industry partner now that it’s raised $550,000 in support of its MyVisionTrack iPhone hyperacuity test.
MyVisionTrack is an FDA-cleared smartphone app for detecting age-related macular degeneration and other age-related visual impairments. Vital Art is in the process of seeking approval for the app in the European Union, MobiHealthNews reported.